Innovating for health in South America

Innovating for health in South America

Ah South America. The land of the samba. And the tango. And Carlos Santana. And the greatest of great footballers. And the Amazon rainforest. And capoeira. And chimichurri. And asado. And carnitas. And pao de queijo. Okay, enough with the food already.


How about also calling it the land of civil unrest? And some extreme poverty. And radical disparities of wealth? And the land of dengue? And Zika? And Chagas?


As glorious and diverse as South American culture is, the continent also is home to a multifaceted health landscape characterised by unique challenges that stem from its diverse socio-economic conditions, health infrastructure, and disease burden. This region, rich in culture and history, confronts public health issues that range from infectious diseases to rising non-communicable diseases (NCDs), each exacerbated by regulatory complexities and a lack of access to essential medicines. Addressing these challenges requires innovative solutions that can adapt to the varied needs of South American countries.


The health challenges of the continent

South America’s disease burden is a complex interplay of infectious diseases, such as dengue fever, Zika virus, and Chagas disease, alongside a growing prevalence of NCDs, including heart disease, diabetes, and cancer.


Non-Communicable Diseases (NCDs): A rising tide

Non-communicable diseases (NCDs) are the leading cause of mortality in South America, contributing to more than 75% of all deaths. The latest WHO data highlights that cardiovascular diseases account for approximately 30% of these deaths, followed closely by cancers, which are responsible for 25%. For instance, Brazil reported an estimated 200,000 deaths from heart disease and 150,000 cancer-related deaths in the latest reporting year, underscoring the urgent need for comprehensive healthcare strategies to address these growing concerns. Diabetes and chronic respiratory diseases also pose significant challenges, with an estimated 8% and 6% of the South American population affected, respectively. These conditions not only lead to premature mortality but also contribute to a decreased quality of life and increased healthcare costs.


Infectious diseases: persistent threats

Despite progress in healthcare, infectious diseases remain prevalent in South America, with dengue, Zika, and Chagas disease posing significant public health threats. The WHO reported over 2 million cases of dengue fever in the Americas in 2019, with the majority occurring in South American countries. Chagas disease, endemic to the region, affects an estimated 6 million people, with less than 1% having access to adequate treatment.


Malaria continues to be a concern, particularly in the Amazon basin, with PAHO reporting over 120,000 cases in 2019 alone. Dengue fever outbreaks are recurrent, affecting tens of thousands of people across various countries, underscoring the need for improved vector control and public health strategies. Brazil recently imposed a dengue emergency in three states with plans to roll out the world’s first dengue vaccination campaign. These diseases highlight the critical need for improved vector control, public health education, and access to healthcare services.


The COVID-19 pandemic further exposed and exacerbated the region’s healthcare system vulnerabilities, from overstretched healthcare facilities to significant disparities in access to care and treatments. The pandemic’s disruption of healthcare services further highlighted the importance of resilient healthcare systems and the need for regional self-sufficiency in pharmaceutical manufacturing.


Regulatory hurdles in pharmaceutical manufacturing

One of the major obstacles to improving healthcare accessibility in South America is the regulatory environment. The process for approving new drugs and facilitating the entry of generic medicines into the market can be cumbersome and varied across countries. This regulatory complexity not only delays access to essential medications but also increases costs, making treatments unaffordable for a significant portion of the population.


Moreover, intellectual property (IP) laws in some South American countries can inhibit the local production of generic drugs, further complicating efforts to achieve pharmaceutical self-sufficiency. Efforts to harmonise regulatory standards and promote regional cooperation, such as those led by the Pan American Network for Drug Regulatory Harmonization (PANDRH), are crucial for overcoming these barriers.


Prevailing diseases lacking treatments

Despite advances in healthcare, several diseases prevalent in South America lack adequate treatments. Chagas disease, a neglected tropical disease caused by the Trypanosoma cruzi parasite, affects millions in the region but has limited treatment options, particularly in its chronic phase. Similarly, leishmaniasis and neglected endemic diseases continue to affect populations without sufficient research and development for new treatments.


Cancer care in South America also faces significant hurdles, with disparities in access to cancer treatments and palliative care. According to PAHO, cancer is a leading cause of death, with approximately 1.3 million new cases and 666,000 deaths annually in the Americas, a substantial portion of which occurs in South America. Access to new oncology drugs and advanced treatments is limited by high costs and regulatory delays.


The path forward: Enter PodTech™️

To address these challenges, South America needs to embrace innovative health solutions and strengthen its pharmaceutical manufacturing capabilities. Modular factory systems like PodTech™️ are the solution. Our prefabricated, portable factories can significantly reduce the time and investment required to establish manufacturing facilities, enabling rapid scale-up of drug production in response to health crises.


Investing in local pharmaceutical production not only improves access to medicines but also fosters economic growth and reduces dependency on imports. Countries like Brazil and Argentina have begun investing in biotechnological research and vaccine production, paving the way for others in the region.


Addressing NCDs and infectious diseases with PodTech™

NCDs, including cardiovascular diseases and cancers, are the leading causes of mortality in South America, while infectious diseases like dengue, Zika, and Chagas disease continue to challenge public health systems. The scalability and flexibility of PodTech™’s modular factories can play a pivotal role in this context by:

  • Accelerating local production of essential medicines: By enabling the rapid establishment of manufacturing facilities, PodTech™ can help produce essential medicines for NCDs and treatments for infectious diseases locally. This reduces reliance on imports and ensures a more stable and accessible supply of critical healthcare products.
  • Supporting public health campaigns: With the capability to quickly scale up production, PodTech™ can support extensive vaccination campaigns and the production of vector control products, crucial for combating infectious diseases prevalent in the region.

Overcoming healthcare system vulnerabilities

The COVID-19 pandemic exposed and exacerbated vulnerabilities in South America’s healthcare systems, from overstretched facilities to disparities in access to care. PodTech™’s solution offers:

  • Rapid deployment for emergency response: The modular nature of PodTech™ factories allows for quick deployment in response to public health emergencies, enhancing the region’s readiness and resilience against future pandemics.
  • Sustainable healthcare infrastructure development: PodTech™ systems are designed with sustainability in mind, reducing construction waste and energy consumption. This aligns with the global shift towards greener healthcare solutions, crucial for the long-term sustainability of health infrastructure in South America.

Navigating regulatory hurdles with PodTech™

Regulatory complexities often delay the introduction of new drugs and the adoption of generic medicines in South America. PodTech™ can facilitate:

  • Streamlined manufacturing processes: By standardising manufacturing modules, PodTech™ can help pharmaceutical companies navigate regulatory hurdles more efficiently, speeding up the drug approval process.
  • Enhanced quality and compliance: Each PodTech™ podule is equipped with advanced control systems and cleanroom facilities, ensuring that manufacturing processes meet stringent regulatory standards, thus fostering trust among regulatory bodies and facilitating quicker market entry.

The path forward with PodTech™

The implementation of PodTech™’s prefabricated modular factory systems across the continent can transform the pharmaceutical landscape by:

  • Making essential drugs more accessible and affordable.
  • Enhancing the region’s capacity to respond to health emergencies.
  • Promoting sustainable development in the pharmaceutical sector.

Imagine a disposables manufacturing unit that comes up in Bogota in 2 years. Or a local pharma manufacturer of the newly-approved malaria vaccine. Or a fresh new factory in Ecuador to manufacture oncology drugs for the entire continent. With PodTech™, it is all possible.


The health landscape in South America, marked by a dual burden of infectious and non-communicable diseases, requires a multi-faceted approach that includes innovative manufacturing solutions, regulatory reform, and increased investment in healthcare infrastructure. By leveraging technologies like PodTech™️’s modular factory systems and fostering regional collaboration, South America can overcome its healthcare challenges, ensuring a healthier future for its diverse populations.


As the region moves forward, the lessons learned from addressing its unique health challenges will not only benefit South America but also offer valuable insights for global health, demonstrating the importance of adaptability, innovation, and resilience in the face of public health challenges.


As we stand at the crossroads of tradition and innovation, the time is now for local pharmaceutical manufacturers to lead the charge towards a healthier South America. By partnering with PodTech™, you have the power to revolutionize healthcare delivery in your country, bringing essential medicines closer to those who need them most. Imagine the impact of locally produced, accessible healthcare solutions on your communities, from the heart of the Amazon to the peaks of the Andes.


Don’t let another day pass in the shadow of healthcare disparities. Contact us today, and let’s build the infrastructure that will safeguard the health of future generations. Together, we can turn the tide against disease, fostering a continent of resilience, health, and prosperity. Your journey towards making a monumental difference in South American healthcare begins with a single step. Take that step with PodTech™—for your people, for your country, for the future.


Request a callback